Catabasis Pharmaceuticals, Inc.
USD8.54
-0.64 (-6.97%)
CEO
Jill Milne
IPO Date
2015-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.07
Prev. Close
$9.18
Day Low
$8.48
Day High
$9.21
52W Low
$1.25
52W High
$10.26
Market Cap
$0.23B
Volume
0.10M
| 100,000 |
| $2.04 |
| 2 Jun 2021 | LAPOINTE ANTHONY GREGG | director | A-Award | Acquired | 100,000 | $2.04 |
| 2 Jun 2021 | Violin Jonathan | director | A-Award | Acquired | 85,000 | $2.04 |
| 2 Jun 2021 | Harshbarger Benjamin | Senior VP, General Counsel | A-Award | Acquired | 400,000 | $2.87 |
| 2 Jun 2021 | KISHBAUCH MICHAEL D | director | A-Award | Acquired | 100,000 | $2.04 |
| 2 Jun 2021 | Milne Jill C. | director, officer: CEO and President | A-Award | Acquired | 1,400,000 | $2.87 |
| 2 Jun 2021 | Callori Fred | director | A-Award | Acquired | 85,000 | $2.04 |
| 2 Jun 2021 | Clauser Noah | Chief Financial Officer | A-Award | Acquired | 600,000 | $2.87 |
| 3 Feb 2021 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | A-Award | Acquired | 1,617 | $0.00 |